| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 10/01/2009 | WO2009071444A9 Novel imaging method |
| 10/01/2009 | WO2009037342A3 Formulation comprising contrast agents for mri comprising an organic polybase |
| 10/01/2009 | WO2009000777A4 Imaging diagnostics by combining contrast agents |
| 10/01/2009 | WO2005067620A9 ANTIBODIES TO MAdCAM |
| 10/01/2009 | US20090249500 System for monitoring bacterial tumor treatment |
| 10/01/2009 | US20090246145 Imaging Correlates of Neurogenesis With MRI |
| 10/01/2009 | US20090246144 System and method for indirectly measuring calcium ion efflux |
| 10/01/2009 | US20090246142 Triggered Self-Assembly of Nanoparticles In Vivo |
| 10/01/2009 | US20090246141 Higher fatty acid triester and amide derivative having diethylenetriamine-type metal chelate structure |
| 10/01/2009 | US20090246140 Methods for identifying and targeting autonomic brain regions |
| 10/01/2009 | US20090246139 Efficient methods to isolate effectors of proteins involved in olfactory or chemosensory pathways and efficient methods to use these effectors to alter organism olfaction, chemosensation, or behavior |
| 10/01/2009 | US20090246137 Pyridyl derivatives as cftr modulators |
| 10/01/2009 | US20090246136 Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration |
| 10/01/2009 | US20090246135 Diagnostic agent |
| 10/01/2009 | US20090246134 Compositions and methods for modulating gated ion channels |
| 10/01/2009 | US20090246132 Epitope bound by MAbs A, B, C or D, where MAbs A, B, C and D have given variable domains; chimeric or humanized for side effect reduction; polymerase chain reaction |
| 10/01/2009 | US20090246131 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies |
| 10/01/2009 | US20090246127 Targeting agents for molecular imaging |
| 10/01/2009 | US20090246125 Magnetic resonance contrast media |
| 10/01/2009 | CA2719623A1 Image-guided therapy of myocardial disease: composition, manufacturing and applications |
| 09/30/2009 | EP2104662A2 Chelating agents |
| 09/30/2009 | EP1530465B1 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 09/30/2009 | EP1453525B1 Selective targeting of apoptotic cells |
| 09/30/2009 | CN101547706A Magnetic resonance imaging contrast agents comprising zinc-containing magnetic metal oxide nanoparticles |
| 09/30/2009 | CN101543633A Novel oral intestinal canal tracer agent |
| 09/30/2009 | CN100544770C Method for detecting and killing epithelial cancer cells |
| 09/30/2009 | CN100544713C Paclitaxel mixed composition and water-in-oil type emulsion formulation for chemoembolization and preparation method thereof |
| 09/29/2009 | US7595431 Mouse models of human prostate cancer |
| 09/29/2009 | CA2376146C Biopsy site marker and process and apparatus for applying it |
| 09/24/2009 | WO2009117688A2 Methods for producing microbubbles |
| 09/24/2009 | WO2009117567A2 Substituted fullerenes as mri contrast agents |
| 09/24/2009 | WO2009117154A1 Odontogenic ameloblast-associated protein as a tumor biomarker |
| 09/24/2009 | WO2009117041A2 Use of pyrene to carry peptides across the blood brain barrier |
| 09/24/2009 | WO2009116408A1 Process for producing core/shell-type semiconductor nanoparticles, and core/shell-type semiconductor nanoparticles |
| 09/24/2009 | WO2009115967A2 Method for the synthesis of hollow spheres |
| 09/24/2009 | WO2009115579A1 Biodegradable nanoshells for delivery of therapeutic and/or imaging molecules |
| 09/24/2009 | WO2009115288A1 Thiostrepton probe |
| 09/24/2009 | WO2009027937A3 Clustered magnetic particles as tracers for magnetic particle imaging |
| 09/24/2009 | WO2009019019A3 Production of targeted mri probes by biocompatible coupling of macromolecules with charged nanoparticles |
| 09/24/2009 | US20090241203 Transgenic animal models of disease |
| 09/24/2009 | US20090241202 Domain-grafted antibodies |
| 09/24/2009 | US20090238768 Multimeric magnetic resonance contrast agents |
| 09/24/2009 | US20090238767 Targeting contrast agents or targeting therapeutic agents for molecular imaging and therapy |
| 09/24/2009 | US20090238766 Bioluminescent construct |
| 09/24/2009 | US20090238765 Fluorescent Contrast Agent |
| 09/24/2009 | US20090238764 Diagnostic therapeutic method |
| 09/24/2009 | US20090238761 Novel Aryl Piperazine Derivatives With Medical Utility |
| 09/24/2009 | US20090238758 Random and non-random alkylene oxide polymer alloy compositions |
| 09/24/2009 | US20090238757 Methods and Compositions for Administering Therapeutic and Diagnostic Agents |
| 09/24/2009 | US20090238756 Image-guided therapy of myocardial disease: composition, manufacturing and applications |
| 09/24/2009 | US20090238755 Use of antibodies or binding portions thereof, probes, ligands, or other biological agents which either recognize an extracellular domain of prostate specific membrane antigen or bind to and are internalized with prostate specific membrane antigen |
| 09/24/2009 | US20090238754 Use of pyrene to carry peptides across the blood brain barrier |
| 09/24/2009 | US20090238436 Composition for imaging reagent |
| 09/24/2009 | DE102008014467A1 Sprayable ultrasonic coupling agent from aqueous solution having gelling agent, where agent is contacted with spray pump and spraying of agent forms peptisation from solution in spray pump, useful for ultrasonic examinations of patient |
| 09/24/2009 | CA2718860A1 Use of pyrene to carry peptides across the blood brain barrier |
| 09/24/2009 | CA2718716A1 Odontogenic ameloblast-associated protein as a tumor biomarker |
| 09/23/2009 | EP2103611A1 Benzoxazole derivatives |
| 09/23/2009 | EP2103313A1 Method for the synthesis of hollow spheres |
| 09/23/2009 | EP2101824A2 Preparation for detection of a salivary malfunction |
| 09/23/2009 | EP1729818B1 Contrast agents for magnetic resonance imaging |
| 09/23/2009 | EP1435935B1 Concentrated x-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions |
| 09/23/2009 | CN101541349A Development of prodrugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety using in vitro/in silico predictions |
| 09/23/2009 | CN101541348A Hydrazone derivatives and uses thereof |
| 09/23/2009 | CN101538313A Peptide-based compounds |
| 09/23/2009 | CN101537193A Vesicle monoamine transporter target bound drug and preparation method thereof |
| 09/23/2009 | CN101537192A Magnetic resonance liver targeting contrast medium and preparation method thereof |
| 09/23/2009 | CN101537190A Peptide-based compounds |
| 09/23/2009 | CN100542615C Medical supersonic coupler with disinfection function and method for preparing the same |
| 09/22/2009 | US7592143 Induction of capacse cascade ; administering apoptosis inducing protein; drug screening; anticancer agents |
| 09/22/2009 | US7591998 Stool marker |
| 09/22/2009 | US7591997 Method for determining the susceptibility of a subject to infection |
| 09/22/2009 | CA2278586C Coated implantable medical device |
| 09/17/2009 | WO2009114776A2 Integrin targeting agents and methods of using same |
| 09/17/2009 | WO2009113704A2 Fluorine-containing compound and method for detecting biomolecule using the same |
| 09/17/2009 | WO2009113295A1 C2orf18 as target gene for cancer therapy and diagnosis |
| 09/17/2009 | WO2009112488A2 Polyether polyol dendron conjugates with effector molecules for biological targeting |
| 09/17/2009 | WO2009111876A1 System and method for magnetic resonance imaging |
| 09/17/2009 | WO2006078979A9 Vectors and methods for genetic immunization |
| 09/17/2009 | WO2004039335A3 Polymer compositions comprising antifibrotic agents, and methods of treatment, pharmaceutical compositions, and methods of preparation therefor |
| 09/17/2009 | US20090234225 Fluorescence detection system |
| 09/17/2009 | US20090234221 Responsive paramagnetic mri contrast agents |
| 09/17/2009 | US20090232741 Optical Imaging |
| 09/17/2009 | US20090232740 Methods of detecting cancer cells and use of same for diagnosing and monitoring treatment of the disease |
| 09/17/2009 | US20090232739 Method of in Vivo Screening for cardiac Toxic Agents Using Teleost |
| 09/17/2009 | US20090232738 Methods for modulating de novo hepatic lipogenesis by modulating XBP-1 activity |
| 09/17/2009 | US20090232737 Purification of proteins |
| 09/17/2009 | US20090232736 Dual specificity antibodies and methods of making and using |
| 09/17/2009 | US20090232733 Diagnostic and Therapeutic Potential of Immune Globulin Intravenous (IGIV) Products |
| 09/17/2009 | US20090232731 Cationic Liposomal Preparations for the Treatment of Rheumatoid Arthritis |
| 09/17/2009 | CA2718382A1 C2orf18 as target gene for cancer therapy and diagnosis |
| 09/17/2009 | CA2718244A1 Polyether polyol dendron conjugates with effector molecules for biological targeting |
| 09/17/2009 | CA2717906A1 System and method for magnetic resonance imaging |
| 09/17/2009 | CA2715034A1 Integrin targeting agents and in-vivo and in-vitro imaging methods using the same |
| 09/16/2009 | EP2100621A1 Polyether polyol dendron conjugates with effector molecules for biological targeting |
| 09/16/2009 | EP2100619A1 Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 09/16/2009 | EP2099498A2 Methods for using optical agents |
| 09/16/2009 | EP2099496A2 Delivery of nanoparticles and/or agents to cells |
| 09/16/2009 | EP2099304A2 Carboranylporphyrins and uses thereof |
| 09/16/2009 | EP1704157B1 Metal complexes having vitamin b12 as a ligand |
| 09/16/2009 | EP1542732B1 Fusion proteins of mycobacterium tuberculosis |